股票行情快报：中关村（000931）2月5日主力资金净卖出262.23万元

Company Overview - Zhongguancun (000931) reported a closing price of 5.2 yuan on February 5, 2026, with a decrease of 0.38% and a turnover rate of 1.22% [1] - The company’s main business segments include biopharmaceuticals and health products, elderly medical services, commercial concrete, and other businesses [1] Financial Performance - For the first three quarters of 2025, Zhongguancun's main revenue was 1.882 billion yuan, a year-on-year decrease of 2.46% [1] - The net profit attributable to shareholders was 49.49 million yuan, down 4.14% year-on-year, while the net profit after deducting non-recurring items increased by 8.99% to 43.64 million yuan [1] - In Q3 2025, the company reported a single-quarter main revenue of 644 million yuan, a decrease of 1.96% year-on-year, and a net profit attributable to shareholders of 10.68 million yuan, down 29.9% year-on-year [1] - The company’s debt ratio stood at 51.09%, with investment income of -1.68 million yuan and financial expenses of 36.13 million yuan, while the gross profit margin was 59.64% [1] Capital Flow Analysis - On February 5, 2026, the net outflow of main funds was 2.62 million yuan, accounting for 5.48% of the total transaction amount, while retail funds saw a net inflow of 1.11 million yuan, representing 2.32% of the total transaction amount [1]